1Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol, 2000,15:290-301.
2Zeisberg M, Maeshima Y, Mosterman B, et al, Ronal fibrosis: extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells. Am J Pathoh,2002,160(6) :2001-2008.
3Kitamura M, Fine LG. The concept of glcsnerular self defence.Kidney Int, 1999,55:1639.
4Cossins J, Dudgeon TJ, Catlin G, et al. Identification of MMP- 18, a putative novel human matrix metalloproteinase. Bichem Biophys Res Commun, 1996, 228 (2) :494-498.
5LI L, Akers K, Eisen AZ, et al. Activation of gelatinase A (72 kDa type Ⅳ collagenase) induced by monensin in normal human fibroblasts.Exp Cell Res, 1997, 232(2):322-330.
6Cecil D,Bemhand B,Georg FH, et al. Regulation of metalloproteinases-2 and-9 by interleukin 13 in mesangial cells. Nephrol Dial Transplant,2003, 18(Suppl) : 254.
7Murphy G, Houbi'echts A, Coekett MI, et al. The N-terminal domain of tissue inhibitor of metalloproteinases-1 by TIMP-1. Nature, 1997:389: 77-81.
8Greene J,Wang M,Lin YE,et al. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Bid Chem,1996,271(48):30375-30380.
9Backer AH, Zaltsman AB, George SJ, et al. Divergent effects of tissue inhibitor of metalloproteinase 21,22, or 23 overexpression on rat vascular .smooth muscle ceil invasion . proliferation and death in vitro. J Clin Invest, 1998,101 (6):1478-1487.
10Li JH, Zhu HI, Huang XR, et al. Smad 7 inhibits fibrotic effect of TGF-beta on renal tubular epithelial cells by blocking Smad 2 activation. J Am Soc Nephrol, 2002, 13(6):1464-1472.
二级参考文献52
1Troen BR.The biology of aging.Mt Sinai J Med,2003,70:3-22.
2Gagliano N,Arosio B,Santambrogio D,et al.Age-dependent expression of fibrosis-related genes and collagen deposition in rat kidney cortex.J Gerontol A Biol Sci Med Sci,2000,55:365-372.
3Duymelinck C,Deng JT,Dauwe SE,et al.Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy.Kidney Int,1998,54:804-818.
4Lin H,Chen X,Wang J,et al.Inhibiton of apoptosis in rat mesangial cells by tissue inhibitor of metalloproteinase-1.Kidney Int,2002,62:60-69.
5Frasca D,Nguyen D,Riley RL,et al.Decreased E12 and/or E47 transcription factor activity in the bone marrow as well as in the spleen of aged mice.J Immunol,2003,170:719-726.
6Kim H,Oda T,Lopez-Guisa J,et al.TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy.J Am Soc Nephrol,2001,12:736-748.
8Gangyong L,Rafael F,Hyeong-Reh CK.Tissue inhibition of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells.Cancer Res,1999,59:6267-6275.
9Martin J,Steadman R,Knowlden J,et al.Differential regulation of matrix metalloproteinases and their inhibitors in human glomerular epithelial cells in vitro.J Am Soc Nephrol,1998,9:1629-1637.
10Schnaper HW. Balance between matrix synthesis and degradation: a determinant of glomerulosclerosis. Pediatr Nephrol, 1995, 9: 104-111.
2Anderson S.Nifedipine versus fosinopril in uninephrectomized diabetic rats[J].Kidney Int,1992,41(4):891-897.
3Steffes MW,Osterby R,Chavers B,et al.Messangial expansion as a central mechanism for loss of kidney function in diabetic patients[J].Diabetes,1989,38:1077-1081.
4Hideaki N,Frederic k Woessner J.Matrix metalloproteinase[J].J Biol Chem,1999,274:21491-21494.
5Suzuki D,Miyazaki M,Jinde K,et al.In situ hybridization studies of matrix metalloproteinase -3,tissue inhibitor of metalloproteinase-1 and type Ⅳ collagen in diabetic nephropathy[J].Kidney Int,1997,52(1):111-119.
